Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity

URN to cite this document:: urn:nbn:de:bvb:355-epub-554673
DOI to cite this document:: 10.5283/epub.55467

Mester, Patricia ; Räth, Ulrich ; Schmid, Stephan

; Amend, Pablo ; Keller, Dennis ; Krautbauer, Sabrina ; Bondarenko, Sofiia ; Müller, Martina ; Buechler, Christa

; Pavel, Vlad

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 29 Jan 2024 12:44

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Insulin-like growth factor-binding protein (IGFBP)-2 is a regulator of anabolic pathways, which become inactivated in severe illness. Here, we measured the serum IGFBP-2 levels of COVID-19 patients with moderate and severe disease as well as healthy controls to identify the associations of serum IGFBP-2 levels with disease severity. Patients with severe COVID-19 had higher serum IGFBP-2 levels ...